Comprehensive Analysis of Adulticidal vs. Non-Arsenical Management Strategies for Canine Heartworm Disease

The clinical management of canine heartworm disease, caused by the filarial nematode  , represents one of the most complex and contentious areas of modern veterinary parasitology. Since the parasite was first identified in the southeastern United States in the mid-19th century, the veterinary community has sought a balance between the total elimination of the parasite and the minimization of host-mediated pathology.1 The fundamental challenge of heartworm therapy lies in the fact that the treatment itself can be as dangerous as the disease; the death of large, foot-long worms within the pulmonary vasculature inevitably leads to thromboembolic events and severe inflammatory cascades.3 This report provides an exhaustive examination of the two primary therapeutic philosophies: the rapid adulticidal approach, primarily utilizing arsenical compounds, and the "slow-kill" or non-arsenical method, which relies on the long-term administration of macrocyclic lactones and antibiotics. By analyzing the history, pharmacology, and physiological impacts of these methods, this report clarifies why the adulticidal protocol remains the gold standard while exploring the socioeconomic and institutional pressures that sustain the use of suboptimal alternatives in private practices and animal shelters.

Historical Evolution of Heartworm Adulticide Therapy

The history of heartworm treatment is a narrative of progression from high-toxicity, low-efficacy metal-based compounds to highly targeted, multi-modal chemotherapeutic protocols. In the early 20th century, the discovery of heartworms in both dogs and cats prompted the search for a chemical agent capable of killing adult worms without killing the host.1 This search led to the development of organic arsenicals, which remained the only viable option for decades despite their significant side effects.

The Thiacetarsamide Era

From the mid-20th century through the 1980s, the primary adulticide of choice was thiacetarsamide sodium, marketed under the trade name Caparsolate.5 This compound was an organic arsenical that required a rigorous and often perilous administration schedule. Clinicians were required to administer the drug intravenously twice daily for two consecutive days.5 The margin of safety for thiacetarsamide was exceptionally narrow; the drug was highly hepatotoxic and nephrotoxic, frequently necessitating hospitalization for the duration of the treatment to monitor liver and kidney function.5

One of the most significant drawbacks of thiacetarsamide was its inconsistent efficacy. While it was relatively effective against male heartworms, it frequently failed to eliminate young female worms, which are more robust and resistant to the drug's effects.6 Research using heartworm transplant models demonstrated that thiacetarsamide killed approximately 92% of young male worms but only 31.6% of young female worms.6 This discrepancy meant that many dogs remained infected even after undergoing the arduous and toxic treatment. Furthermore, the intravenous administration carried the risk of severe perivascular sloughing if even a small amount of the drug leaked outside the vein, leading to localized tissue necrosis and significant pain for the animal.5

The Melarsomine Revolution

The introduction of melarsomine dihydrochloride in the mid-1990s marked a paradigm shift in veterinary parasitology.7 Marketed as Immiticide and later as the generic Diroban, melarsomine offered a significantly higher margin of safety and a more convenient administration route than thiacetarsamide.7 Melarsomine is administered via deep intramuscular injection into the epaxial (lumbar) muscles, specifically in the  to  region.7

Unlike its predecessor, melarsomine demonstrated high efficacy against both male and female worms, as well as immature adults at least four months of age.7 The development of melarsomine was accompanied by a refinement in dosing protocols. Initially, the manufacturer recommended a two-dose regimen (two injections 24 hours apart), which killed approximately 90% of adult worms.5 However, clinical experience and further research led to the adoption of the "three-dose" or "split-dose" protocol, which involves a single initial injection followed 30 days later by two injections 24 hours apart.5 This protocol is now recognized by the American Heartworm Society (AHS) as the most effective and safest method, killing more than 98% of adult worms while reducing the severity of pulmonary thromboembolism by staggering the death of the parasite burden.11

Pathophysiology of Infection and the Mechanism of Adulticides

To understand why the adulticidal approach is preferred, one must first appreciate the devastating impact of   on the canine host. Heartworms do not reside in the heart itself but rather in the pulmonary arteries that carry blood from the heart to the lungs.3 The physical presence of these parasites, which can grow to 30 cm in length, causes mechanical irritation and damage to the delicate endothelial lining of the vessels.2

Vascular Remodeling and Pulmonary Hypertension

The host's response to the presence of heartworms involves a process known as villous endarteritis. The endothelial cells of the pulmonary arteries proliferate, creating a roughened, "shag carpet" appearance on the interior of the vessel walls.13 This remodeling leads to a loss of vessel elasticity and a narrowing of the arterial lumen, which increases resistance to blood flow.3 The right side of the heart must then pump harder to overcome this resistance, eventually leading to right-sided congestive heart failure.3

When an adulticide like melarsomine is administered, it acts by interfering with the parasite's metabolism, leading to its death within 7 to 10 days.7 As the worms die, they dislodge from their attachments in the pulmonary arteries and are carried by the blood flow into the smaller, distal branches of the lungs.4 This process, pulmonary thromboembolism (PTE), is an inevitable consequence of successful treatment.4 The fragments of dead worms cause localized inflammation, edema, and hemorrhage in the lung parenchyma.9 This is why exercise restriction is so vital; increased heart rate and blood flow during activity can force worm fragments deeper into the lungs, exacerbating the embolic damage and potentially leading to fatal respiratory distress.15

The Role of Adjunctive Medications in Adulticide Therapy

Modern adulticidal protocols are not merely about the administration of melarsomine; they are comprehensive, multi-drug regimens designed to mitigate the risks of worm death.

1. Macrocyclic Lactones: Medications such as ivermectin, milbemycin oxime, or moxidectin are administered for two months prior to melarsomine injections.9 The purpose of this "pretreatment" is to eliminate the younger larvae ( and ) and allow the "juvenile" worms (those between 2 and 4 months old) to mature into an age where they are more susceptible to melarsomine, thereby closing the "susceptibility gap".9
2. Doxycycline: This antibiotic is administered for 28-30 days prior to adulticide therapy to target , a symbiotic bacterium found within heartworms.18 Depleting  before the worms die significantly reduces the inflammatory response in the host's lungs when the parasite fragments are released.13
3. Glucocorticoids (Prednisone): Prednisone is administered in a tapering dose concurrently with melarsomine injections to control the clinical signs of PTE and reduce parenchymal inflammation.9

The Discovery and Biological Significance of Wolbachia Pipientis

The discovery of the bacterial endosymbiont  in   in the 1970s and 1990s revolutionized the understanding of heartworm pathogenesis.18  is a Gram-negative rickettsial organism that maintains a symbiotic relationship with most filarial nematodes.18 In the case of . ,  is present in all life stages and is essential for the worm's development, reproduction, and survival.22

Metabolic Symbiosis

Genomic studies have revealed that  provides essential metabolic pathways that the heartworm itself lacks. Specifically, the bacteria are involved in the synthesis of heme, riboflavin, flavin adenine dinucleotide (FAD), and glutathione, all of which are critical for the worm's energy metabolism and molting processes.22 Without these bacterial partners, the heartworm becomes sterile and its lifespan is significantly shortened.24

Pathogenesis and Inflammation

From a clinical perspective, the most important aspect of  is the release of  surface proteins (WSPs) when heartworms die.13 These proteins act as potent triggers for the host’s innate immune system, leading to the recruitment of neutrophils and macrophages to the pulmonary arteries.13 This inflammatory response is responsible for much of the acute pulmonary pathology seen during heartworm treatment. By incorporating doxycycline into the treatment protocol, veterinarians can "pre-clear" these bacteria, thereby "quieting" the host's immune response before the adult worms are killed by melarsomine.18

The "Slow-Kill" Method: Description and History

The "slow-kill" or "soft-kill" method refers to a non-arsenical treatment approach that utilizes the long-term, continuous administration of macrocyclic lactone preventives, often in conjunction with doxycycline, to eliminate adult heartworms.30 This method emerged not as a designed therapeutic strategy but as an accidental discovery of the "reach-back" or "safety-net" effect of drugs like ivermectin.33

History of the "Reach-Back" Effect

In the 1980s and 1990s, researchers noticed that dogs receiving monthly ivermectin preventives who had missed doses sometimes remained heartworm-negative or had lower worm burdens than expected.33 Further investigation revealed that ivermectin, when administered monthly for 12 to 30 months, had a slow adulticidal effect.33 A landmark study by McCall et al. in 2001 demonstrated that 30 months of monthly ivermectin at preventive doses reduced a heartworm burden by approximately 94%.35 This discovery led some practitioners to use preventives as a primary treatment for heartworm-positive dogs when arsenical therapy was unavailable or unaffordable.4

Modern Slow-Kill Protocols (Moxi-Doxy)

With the discovery of ’s role, the slow-kill method evolved. The most effective non-arsenical protocol currently studied involves the combination of topical moxidectin (applied monthly) and doxycycline (administered for 28 days).30 Moxidectin is preferred over ivermectin for this approach due to its unique pharmacokinetics; it is more lipophilic and has a longer half-life, which translates to a more potent and rapid adulticidal effect.31 Experimental studies of this "moxi-doxy" protocol have shown up to 95.9% efficacy in eliminating adult heartworms within 10 months.31

Despite these improvements, the slow-kill method remains a "salvage procedure" in the eyes of the AHS and CAPC.15 The primary reason is the timeline; while melarsomine clears the infection in 90 days, slow-kill can take one to three years, during which time the dog remains a reservoir of infection and continues to suffer progressive vascular damage.15

Why Adulticidal Therapy is the Preferred Method

The preference for the three-dose melarsomine protocol over the slow-kill method is based on three critical pillars: the halting of pathology, the elimination of the transmission reservoir, and the prevention of drug resistance.

Halting Progressive Damage

Heartworm disease is a progressive, inflammatory condition. As long as adult heartworms are present in the pulmonary arteries, they cause irreversible damage to the vessel walls and the lung tissue.15 Studies have shown that radiographic signs of disease—such as arterial enlargement and parenchymal scarring—continue to worsen in dogs undergoing slow-kill treatment, mirroring the progression seen in untreated dogs during the first year of therapy.32 In contrast, adulticidal therapy eliminates the worms quickly, allowing the inflammatory process to subside and the body to begin repairing the damage much sooner.4

Elimination of the "Infection Reservoir"

A dog infected with adult heartworms that produces microfilariae is a source of infection for the entire local community.14 In high-prevalence areas, a single untreated dog can significantly increase the risk for neighboring pets. The adulticidal protocol rapidly renders a dog amicrofilaremic and antigen-negative, effectively removing them as a source of infection within a few months.9 The slow-kill method, by definition, leaves the dog infected for years, prolonging the period during which they can contribute to the local parasite population.35

Prevention of Macrocyclic Lactone Resistance

One of the most pressing concerns in modern veterinary medicine is the development of heartworm strains that are resistant to macrocyclic lactones.34 This resistance has already been documented in the Mississippi Delta region.34 The use of the slow-kill method is widely believed to contribute to this problem.34 By exposing adult heartworms and their microfilariae to sub-lethal doses of preventives for months or years, the slow-kill method creates a perfect environment for the selection of resistant phenotypes.34 In contrast, adulticide therapy uses arsenicals, a different class of drug, and eliminates the worms quickly, providing no opportunity for the development of resistance to preventives.11

Why Veterinarians Still Use the Slow-Kill Method

If the slow-kill method is medically inferior and carries significant risks, its continued use in veterinary practice requires a nuanced explanation. The persistence of this method is driven by a combination of socioeconomic factors, patient stability, and geographic constraints.

Socioeconomic Barriers and the "Socioeconomic Disease"

Heartworm disease is frequently described as a "socioeconomic disease" because it disproportionately affects pets owned by individuals with limited financial resources.30 The cost of the AHS-recommended adulticidal protocol is substantial, often exceeding  when diagnostics, medication, and follow-up care are included.43 For many pet owners, this expense is simply prohibitive.

When faced with a heartworm-positive diagnosis and an owner who cannot afford the gold-standard treatment, the veterinarian is confronted with a difficult ethical dilemma. The options are often to provide no treatment, to euthanize the animal, or to employ the slow-kill method as a "salvage" procedure.30 In this context, slow-kill is viewed through the lens of the "least harm principle"—it is better than doing nothing, as it at least prevents the acquisition of new heartworms and may eventually clear the existing infection.30

Patient Stability and Contraindications

Not all dogs are immediate candidates for melarsomine therapy. Dogs with Class 4 heartworm disease, also known as Caval Syndrome, are in critical condition; the worm burden is so high that the parasites have backed up into the right atrium and the vena cava, causing mechanical obstruction of blood flow.8 These dogs require surgical removal of the worms rather than chemical adulticides.8 Similarly, dogs with severe, uncontrolled heart failure or other life-threatening comorbidities may be too unstable to withstand the embolic risks of rapid worm death.9 In these cases, a veterinarian may choose to stabilize the dog with macrocyclic lactones and doxycycline (effectively a slow-kill approach) until the animal is healthy enough for melarsomine, or as a permanent strategy if the dog remains too fragile for adulticides.4

Geographic and Regulatory Unavailability

In some parts of the world, melarsomine is not registered for use or is simply unavailable due to supply chain issues.30 In these regions, practitioners have no choice but to rely on non-arsenical protocols.30 This has led to a significant body of research from Europe and South America on the efficacy of moxidectin and doxycycline combinations, which has subsequently informed salvage protocols in the United States when melarsomine has faced manufacturing shortages.15

Management in the Shelter Environment: Institutional Realities

Animal shelters represent a unique front in the battle against heartworm disease. Shelters often take in stray or surrendered animals with unknown veterinary histories, resulting in a high prevalence of heartworm-positive cases.35 The decision-making process in a shelter is governed by "Capacity for Care" (C4C)—the ability of the organization to provide for the needs of all its animals while meeting its mission.30

The Length of Stay (LOS) Challenge

For a shelter, the single greatest barrier to the AHS-recommended protocol is the time required. The protocol takes roughly 120 days from diagnosis to the end of exercise restriction.35 Keeping a dog kenneled for four months increases the "Length of Stay" (LOS), which consumes precious kennel space that could have been used to save multiple other animals during that same period.35 Furthermore, prolonged sheltering is detrimental to a dog’s behavioral health; the stress of the kennel environment can lead to depression, anxiety, and aggression, making the dog less adoptable.30

Resource Allocation and the "War Zone" Approach

Shelters operate on limited budgets. The cost of treating one heartworm-positive dog with melarsomine can be equivalent to the cost of vaccinating and spaying dozens of other animals.30 Consequently, many shelters must adopt a "war zone" approach to medicine.35 In a war zone, clinicians cannot always provide the "gold standard" but instead provide the best care possible with the resources at hand.

Shelters often utilize one of several management models for heartworm-positive dogs:

• Modified Adulticide: Using a two-injection melarsomine protocol to save time and money, despite its lower efficacy compared to the three-dose protocol.30
• Adopt-and-Treat: The dog is adopted out, and the adopter is provided with the medications and instructions to complete the treatment with a private veterinarian.35
• Slow-Kill Initiation: The shelter starts the dog on doxycycline and a macrocyclic lactone preventive immediately upon diagnosis and encourages the adopter to continue this as a salvage treatment if they cannot afford injections.30

Is the Slow-Kill Method Unhealthy for Dogs at the Kennel?

The question of whether the use of slow-kill in a shelter or kennel environment is "unhealthy" must be viewed through two distinct lenses: the health of the infected individual and the health of the other dogs in the facility.

Health of the Infected Dog in the Kennel

From the perspective of the individual infected dog, the slow-kill method is undeniably suboptimal. As established, heartworms continue to cause damage to the lungs and heart as long as they remain alive.15 In a high-stress kennel environment, the health of these dogs is further compromised. The noise and activity of a shelter make it extremely difficult to enforce the "strict rest" required for heartworm-positive dogs.47 Even without an adulticide, the natural death of heartworms or their stunted fitness from slow-kill can cause embolic events.17 If a dog in a kennel becomes excited and begins barking or jumping, they are at a higher risk of suffering respiratory distress or sudden death due to these existing worms.17

Health of the Broader Kennel Population (Transmission)

The primary concern for a kennel manager is whether a heartworm-positive dog on the slow-kill method poses a threat to the other residents. Heartworms are not contagious through direct contact; they require a mosquito vector.14 A dog on the slow-kill method may harbor microfilariae for several months or even years.35 If a mosquito bites the infected dog and then bites a healthy dog in the kennel, the infection can spread.

However, the risk of transmission is significantly mitigated by the inclusion of doxycycline in the protocol. Research has conclusively shown that when heartworm-infected dogs are treated with doxycycline for 28 days, the microfilariae they produce are rendered "incompetent".24 These microfilariae may still be ingested by a mosquito, and they may even develop into  larvae, but they are unable to complete their development into adult heartworms when transmitted to a new dog.24 Therefore, as long as the shelter is using a "moxi-doxy" or "ivermectin-doxy" protocol, the infected dog poses a minimal transmission risk to the rest of the kennel after the first month of treatment.20

The Danger of Resistance Selection

The broader health risk of the slow-kill method in a kennel setting is its role in fostering drug resistance. If a shelter regularly uses slow-kill for its residents, they may be inadvertently selecting for heartworm strains that are less susceptible to preventives.34 When these dogs are eventually adopted or transported to other regions, they carry these potentially resistant strains with them, which can then be spread to the local mosquito and canine populations in their new homes.17 This is why the AHS and ASV strongly recommend against the long-term use of slow-kill in shelters and emphasize the importance of immediate, effective adulticide therapy whenever possible.35

Regional Context: Heartworm Management in Texas

The state of Texas represents one of the most high-pressure environments for heartworm management in the United States. The state’s diverse climate, ranging from humid subtropical in the east to semi-arid in the west, supports a massive and varied population of mosquito vectors.51

Mosquito Vectors and Transmission in East Texas

In areas like Walker County and the city of Huntsville, heartworm transmission is a year-round threat. The region is home to several highly competent mosquito species, including Aedes aegypti (the yellow fever mosquito), Aedes albopictus (the Asian tiger mosquito), and Culex quinquefasciatus (the southern house mosquito).51 These species are not only prolific biters of dogs but are also increasingly adapted to urban environments, breeding in small containers and drainage ditches near homes.51

Studies conducted by Texas A&M University have shown that heartworm prevalence in south and east Texas can reach as high as 40.8% in pet dogs who are not receiving consistent preventive care.52 This environmental pressure means that shelters in the Huntsville area are constantly inundated with heartworm-positive dogs, making the choice between adulticide and slow-kill a daily operational reality.

Local Shelter and Clinic Policies in Huntsville and Beyond

Local organizations have developed specific protocols to address this crisis. For example, the Walker County Veterinary Center emphasizes a rigorous preventative schedule starting at 8 weeks of age.55 In the broader region, organizations like Texas Litter Control and the Texas Foundation for Animal Care provide low-cost options for the community.42

Conclusion: Synthesis and Recommendations

The management of canine heartworm disease is a study in the balance between medical perfection and pragmatic reality.

Summary of the Adulticidal Method

The three-dose melarsomine protocol is the preferred method for the following reasons:

• Efficacy: It eliminates virtually all adult worms (98%+) in a controlled 90-day window.5
• Disease Arrest: It halts the inflammatory damage to the pulmonary arteries far more quickly than slow-kill.4
• Public Health: It rapidly clears the dog as a reservoir of infection and minimizes the risk of drug resistance.34

Summary of the Slow-Kill Method

The slow-kill method is medically considered a salvage procedure because:

• Duration: It takes 12-36 months to clear an infection, during which the dog continues to suffer vascular damage.15
• Uncertainty: The timing of worm death is unpredictable, making exercise restriction difficult to enforce for the years required.4
• Resistance: It poses a significant risk to the long-term effectiveness of heartworm preventives by potentially selecting for resistant strains.34

Final Assessment for Shelters and Owners

While slow-kill is not in the "best interest" of the individual dog’s cardiovascular health, it remains a tool in the veterinarian’s arsenal because it is "better than nothing" for owners with severe financial constraints or for dogs that are clinically unstable.30 In the kennel environment, slow-kill is "unhealthy" for the infected dog due to the inability to enforce quiet rest, but it does not necessarily pose a transmission risk to other dogs if and only if doxycycline is used to render the microfilariae incompetent.20

Ultimately, the goal of every practitioner and shelter manager should be to facilitate adulticide therapy whenever possible. This can be achieved through the use of generic melarsomine to reduce costs, the utilization of foster homes to provide the necessary quiet environment for recovery, and the education of the public on the simple fact that prevention is vastly cheaper and safer than any form of treatment.30 In high-transmission regions like Huntsville, Texas, the battle against heartworm disease requires a community-wide commitment to year-round prevention and the rejection of suboptimal salvage procedures in favor of the medical gold standard.

Works cited

1. Dirofilaria immitis: The monster then and now - DVM360, accessed March 13, 2026, https://www.dvm360.com/view/dirofilaria-immitis-the-monster-then-and-now
2. Dirofilaria immitis - Wikipedia, accessed March 13, 2026, https://en.wikipedia.org/wiki/Dirofilaria_immitis
3. Heartworm Resources List, accessed March 13, 2026, https://heartwormsociety.org/heartworm-resources-list
4. Dog Heartworm Treatment: Side Effects, Aftercare, and Success Rates - Dispomed, accessed March 13, 2026, https://www.dispomed.com/dog-heartworm-treatment-side-effects-aftercare-and-success-rates/
5. Examination of the “susceptibility gap” in the treatment of canine heartworm infection - PMC, accessed March 13, 2026, https://pmc.ncbi.nlm.nih.gov/articles/PMC5688481/
6. thiacetarsamide - CABI Digital Library, accessed March 13, 2026, https://www.cabidigitallibrary.org/doi/pdf/10.5555/20063072608
7. IMMITICIDE® (melarsomine dihydrochloride) Sterile Powder: Approved by the FDA as a canine heartworm treatment | dvm360, accessed March 13, 2026, https://www.dvm360.com/view/immiticide-melarsomine-dihydrochloride-sterile-powder-approved-by-the-fda-as-a-canine-heartworm-treatment
8. IMMITICIDE® (melarsomine dihydrochloride) for Heartworm Disease, accessed March 13, 2026, https://animalhealth.boehringer-ingelheim.com/pets/canine/products/therapeutics/immiticide
9. Canine Heartworm Disease: Principles of Treatment - Today's Veterinary Practice, accessed March 13, 2026, https://todaysveterinarypractice.com/parasitology/ahs-heartworm-hotline-canine-heartworm-disease-principles-of-treatment/
10. UPDATE ON THE ROLE OF WOLBACHIA IN HEARTWORMS AND THE POSSIBLE USE OF TETRACYCLINES IN TREATMENT STRATEGIES - CABI Digital Library, accessed March 13, 2026, https://www.cabidigitallibrary.org/doi/pdf/10.5555/20103181754
11. Adulticide Treatment: Minimizing Melarsomine Complications - American Heartworm Society, accessed March 13, 2026, https://www.heartwormsociety.org/resources/65-clinical-faqs/315-adulticide-treatment-minimizing-melarsomine-complications
12. Heartworm - Companion Animal Parasite Council, accessed March 13, 2026, https://capcvet.org/guidelines/heartworm/
13. Heartworm Treatment for Dogs - Veterinary Partner - VIN, accessed March 13, 2026, https://veterinarypartner.vin.com/default.aspx?pid=19239&catId=102899&id=4951486&ind=126&objTypeID=1007
14. Heartworm Disease - College of Veterinary Medicine, accessed March 13, 2026, https://vet.osu.edu/sites/default/files/documents/Heartworm%20Fact%20Sheet%2020200123.pdf
15. The AHS Protocol vs. “Slow Kill” - American Heartworm Society, accessed March 13, 2026, https://www.heartwormsociety.org/resources/65-clinical-faqs/507-the-ahs-protocol-vs-slow-kill
16. Heartworm disease | Cornell University College of Veterinary Medicine, accessed March 13, 2026, https://www.vet.cornell.edu/departments-centers-and-institutes/riney-canine-health-center/canine-health-information/heartworm-disease
17. Treating Heartworm Disease in Shelter Dogs: 500+ Cases (and counting!) - Maddie's Fund, accessed March 13, 2026, https://www.maddiesfund.org/assets/documents/Institute/Treating%20Heartworm%20500%20Cases%20Transcript.pdf
18. Clinical benefits of incorporating doxycycline into a canine heartworm treatment protocol, accessed March 13, 2026, https://pmc.ncbi.nlm.nih.gov/articles/PMC5688473/
19. Real-time PCR and immunohistochemistry detection of Wolbachia in adult Dirofilaria immitis from dogs treated with doxycycline an, accessed March 13, 2026, https://d-nb.info/1365657094/34
20. Wolbachia and Heartworm: Why Doxycycline Is Needed in Heartworm Treatment | Today's Veterinary Practice, accessed March 13, 2026, https://todaysveterinarypractice.com/parasitology/ahs-heartworm-hotlinewolbachia-heartworm-doxycycline-needed-heartworm-treatment/
21. Our story - World Mosquito Program, accessed March 13, 2026, https://www.worldmosquitoprogram.org/en/about-us/our-story
22. HOW WOLBACHIA DIROFILARIA IMMITIS INTERACT - CABI Digital Library, accessed March 13, 2026, https://www.cabidigitallibrary.org/doi/pdf/10.5555/20063121682
23. (PDF) In vitro molting of Dirofilaria immitis third-stage larvae derived from microfilariae collected from doxycycline-treated dogs - ResearchGate, accessed March 13, 2026, https://www.researchgate.net/publication/392370135_In_vitro_molting_of_Dirofilaria_immitis_third-stage_larvae_derived_from_microfilariae_collected_from_doxycycline-treated_dogs
24. Doxycycline in the Management of Heartworm Disease - Today's Veterinary Practice, accessed March 13, 2026, https://todaysveterinarypractice.com/parasitology/heartworm-hotline-doxycycline-in-the-management-of-heartworm-disease/
25. Heartworm Disease in Dogs, Cats, and Ferrets - Circulatory System - MSD Veterinary Manual, accessed March 13, 2026, https://www.msdvetmanual.com/circulatory-system/heartworm-disease/heartworm-disease-in-dogs-cats-and-ferrets
26. Effects of doxycycline on heartworm embryogenesis, transmission, circulating microfilaria, and adult worms in microfilaremic dogs - PubMed, accessed March 13, 2026, https://pubmed.ncbi.nlm.nih.gov/25458121/
27. Inability of Dirofilaria immitis infective larvae from mosquitoes fed on blood from microfilaremic dogs during low-dose and short-treatment regimens of doxycycline and ivermectin to complete normal development in heartworm naïve dogs - PMC, accessed March 13, 2026, https://pmc.ncbi.nlm.nih.gov/articles/PMC10262448/
28. (PDF) Dirofilaria Immitis Transmission by Treatment of Heartworm Microfilaremic Dogs with Doxycycline - ResearchGate, accessed March 13, 2026, https://www.researchgate.net/publication/400500268_Dirofilaria_Immitis_Transmission_by_Treatment_of_Heartworm_Microfilaremic_Dogs_with_Doxycycline
29. Effects of doxycycline on early infections of Dirofilaria immitis in dogs - ResearchGate, accessed March 13, 2026, https://www.researchgate.net/publication/49942989_Effects_of_doxycycline_on_early_infections_of_Dirofilaria_immitis_in_dogs
30. An Accessible Alternative to Melarsomine: “Moxi-Doxy” for Treatment of Adult Heartworm Infection in Dogs - PMC, accessed March 13, 2026, https://pmc.ncbi.nlm.nih.gov/articles/PMC8353148/
31. Heartworm adulticide treatment: a tropical perspective - PMC - NIH, accessed March 13, 2026, https://pmc.ncbi.nlm.nih.gov/articles/PMC10141906/
32. "Slow-Kill" Heartworm Treatment: Myths and Misconceptions - Idiopathic Issues, accessed March 13, 2026, https://blog.vetprep.com/slow-kill-heartworm-treatment-myths-and-misconceptions
33. The safety-net story about macrocyclic lactone heartworm preventives: A review, an update, and recommendations - ResearchGate, accessed March 13, 2026, https://www.researchgate.net/publication/7565984_The_safety-net_story_about_macrocyclic_lactone_heartworm_preventives_A_review_an_update_and_recommendations
34. Investigating management choices for canine heartworm disease in northern Mississippi, accessed March 13, 2026, https://pmc.ncbi.nlm.nih.gov/articles/PMC5688398/
35. Managing Heartworm Disease in Shelter Animals, accessed March 13, 2026, https://www.heartwormsociety.org/resources/65-clinical-faqs/281-managing-heartworm-disease-in-shelter-animals
36. HEARTWORM TREATMENT: WHY NOT SLOW-KILL? NEW ..., accessed March 13, 2026, https://www.cabidigitallibrary.org/doi/pdf/10.5555/20163321293
37. QUARTERLY UPDATE - American Heartworm Society, accessed March 13, 2026, https://d3ft8sckhnqim2.cloudfront.net/images/bulletin/AHS-1807-Jul-18-Summer-Bulletin.pdf?1534890175
38. Is the slow kill method of heartworm treatment effective? - Dogtopia, accessed March 13, 2026, https://www.dogtopia.com/faq/is-the-slow-kill-method-of-heartworm-treatment-effective/
39. HEARTWORM DISEASE - American Veterinary Medical Association, accessed March 13, 2026, https://ebusiness.avma.org/files/ProductDownloads/mcm-client-brochures-heartworm-2025.pdf
40. 03 Why Not Slow Kill? Patient-Focused Reasons (Clarke Atkins) - YouTube, accessed March 13, 2026, https://www.youtube.com/watch?v=utptRFuZ5Ac
41. Managing Heartworm Disease in Shelter Animals | Today's Veterinary Practice, accessed March 13, 2026, https://todaysveterinarypractice.com/parasitology/ahs-heartworm-hotline-managing-heartworm-disease-in-shelter-animals/
42. Why We Exist - Texas Foundation for Animal Care, accessed March 13, 2026, https://texasfoundationac.org/why-we-exist
43. The cost of heartworm prevention vs. treatment in dogs - Vetster, accessed March 13, 2026, https://vetster.com/en/wellness/the-cost-of-heartworm-prevention-vs-treatment-in-dogs
44. Understanding the Cost of Heartworm Treatment and Why It's Worth It, accessed March 13, 2026, https://www.marketplaceveterinaryclinic.com/blog/1325601-understanding-the-cost-of-heartworm-treatment-and-why-its-worth-it
45. Study: Increasing Access to Heartworm Treatment for Dogs in Shelters, accessed March 13, 2026, https://sheltermedicine.vetmed.ufl.edu/research/current-studies/heartworm-treatment-study/
46. Heartworm Management - Sheltervet.org, accessed March 13, 2026, https://www.sheltervet.org/assets/docs/Heartworm_Management_10_2024.pdf
47. Why can't heartworm positive dogs be treated at the shelter? - Humane Society of the New Braunfels Area, accessed March 13, 2026, https://hsnba.org/why-cant-heartworm-positive-dogs-be-treated-at-the-shelter/
48. Heartworm Treatment Shelter Program - Mazie's Mission, accessed March 13, 2026, https://www.maziesmission.org/heartworm-program
49. What if the dog I'd like to adopt is heartworm positive? - SPCA of Texas, accessed March 13, 2026, https://spcaoftexas.freshdesk.com/en/support/solutions/articles/72000528856-what-if-the-dog-i-d-like-to-adopt-is-heartworm-positive-
50. Minimizing Heartworm Transmission in Relocated Dogs, accessed March 13, 2026, https://d3ft8sckhnqim2.cloudfront.net/images/Relocating-HW-Dogs.pdf?1610058246
51. Mosquito Vectors in South Texas, accessed March 13, 2026, https://www.dshs.texas.gov/sites/default/files/borderhealth/TFBHO-Docs/handouts/Mosquito-Vectors-in-South-Texas-12-07-2023.pdf
52. High prevalence of canine heartworm, Dirofilaria immitis, in pet dogs in south Texas, USA, with evidence of Aedes aegypti mosquitoes contributing to transmission - PMC, accessed March 13, 2026, https://pmc.ncbi.nlm.nih.gov/articles/PMC9635171/
53. Mosquitos and the Diseases they transmit - AustinTexas.gov, accessed March 13, 2026, https://www.austintexas.gov/sites/default/files/files/Health/Environmental/mosquitoes_diseases.pdf
54. High prevalence of canine heartworm, Dirofilaria immitis, in pet dogs in south Texas, USA, with evidence of Aedes aegypti mosquitoes contributing to transmission - PubMed, accessed March 13, 2026, https://pubmed.ncbi.nlm.nih.gov/36329477/
55. Canine Health Schedules - Walker County Veterinary Center, accessed March 13, 2026, https://walkercountyvet.com/wp-content/uploads/2023/03/CanineHealthScheduleWCVC.pdf
56. Texas Litter Control - Low Cost Veterinarian, Vaccinations, accessed March 13, 2026, https://texaslittercontrol.org/
57. Animal Shelter - Conroe, TX, accessed March 13, 2026, https://www.cityofconroe.org/services/animal_shelter.php